Regulation of thymic NKT cell development by the B7-CD28 costimulatory pathway

Journal of Immunology

Volumn 181, Issue 2, 2008, Pages 907-917

  Williams, Joy A ^a   Lumsden, Joanne M ^c   Yu, Xiang ^d   Feigenbaum, Lionel ^e   Zhang, Jingjing ^a   Steinberg, Seth M ^a   Hodes, Richard J ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c NAVAL MEDICAL RESEARCH CENTER   (United States)

^d SuperArray Bioscience Corporation   (United States)

^e SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; CD28 ANTIGEN; B7 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CELL COUNT; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CHIMERA; CONTROLLED STUDY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; THYMUS; TRANSGENIC MOUSE; ANIMAL; C57BL MOUSE; CYTOLOGY; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; NATURAL KILLER CELL;

ANIMALS; ANTIGENS, CD1; ANTIGENS, CD28; ANTIGENS, CD80; CELL DIFFERENTIATION; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; THYMUS GLAND;

EID: 49049096766     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.2.907     Document Type: Article

References (54)

1. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336.
2. Godfrey, D. I., H. R. MacDonald, M. Kronenberg, M. J. Smyth, and L. Van Kaer. 2004. NKT cells: what's in a name? Nat. Rev. Immunol. 4: 231-237.
3. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al. 1997. CD1d-restricted and TCR-mediated activation of vα14 NKT cells by glycosylceramides. Science 278: 1626-1629. (Pubitemid 27516282)
4. Burdin, N., L. Brossay, Y. Koezuka, S. T. Smiley, M. J. Grusby, M. Gui, M. Taniguchi, K. Hayakawa, and M. Kronenberg. 1998. Selective ability of mouse CD1 to present glycolipids: α-galactosylceramide specifically stimulates Vα14+ NK T lymphocytes. J. Immunol. 161: 3271-3281. (Pubitemid 128767716)
5. Yoshimoto, T., and W. E. Paul. 1994. CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179: 1285-1295. (Pubitemid 24091787)
6. + NK T cells associated with disease development in autoimmune-prone mice. J. Immunol. 156: 4035-4040.
7. Taniguchi, M., M. Harada, S. Kojo, T. Nakayama, and H. Wakao. 2003. The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21: 483-513. (Pubitemid 37174539)
8. + cell development. J. Immunol. 159: 5931-5935.
9. Sivakumar, V., K. J. Hammond, N. Howells, K. Pfeffer, and F. Weih. 2003. Differential requirement for Rel/nuclear factor κB family members in natural killer T cell development. J. Exp. Med. 197: 1613-1621. (Pubitemid 36745337)
10. Stanic, A. K., J. S. Bezbradica, J. J. Park, N. Matsuki, A. L. Mora, L. Van Kaer, M. R. Boothby, and S. Joyce. 2004. NF-κB controls cell fate specification, survival, and molecular differentiation of immunoregulatory natural T lymphocytes. J. Immunol. 172: 2265-2273.
11. Elewaut, D., R. B. Shaikh, K. J. Hammond, H. De Winter, A. J. Leishman, S. Sidobre, O. Turovskaya, T. I. Prigozy, L. Ma, T. A. Banks, et al. 2003. NIKdependent RelB activation defines a unique signaling pathway for the development of Vα14i NKT cells. J. Exp. Med. 197: 1623-1633. (Pubitemid 36745338)
12. Townsend, M. J., A. S. Weinmann, J. L. Matsuda, R. Salomon, P. J. Farnham, C. A. Biron, L. Gapin, and L. H. Glimcher. 2004. T-bet regulates the terminal maturation and homeostasis of NK and Vα14i NKT cells. Immunity 20: 477-494.
13. Gadue, P., N. Morton, and P. L. Stein. 1999. The Src family tyrosine kinase Fyn regulates natural killer T cell development. J. Exp. Med. 190: 1189-1196. (Pubitemid 29496512)
14. Eberl, G., B. Lowin-Kropf, and H. R. MacDonald. 1999. Cutting edge: NKT cell development is selectively impaired in Fyn-deficient mice. J. Immunol. 163: 4091-4094. (Pubitemid 29474468)
15. Pasquier, B., L. Yin, M. C. Fondaneche, F. Relouzat, C. Bloch-Queyrat, N. Lambert, A. Fischer, G. de Saint-Basile, and S. Latour. 2005. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J. Exp. Med. 201: 695-701. (Pubitemid 40395115)
16. Nichols, K. E., J. Hom, S. Y. Gong, A. Ganguly, C. S. Ma, J. L. Cannons, S. G. Tangye, P. L. Schwartzberg, G. A. Koretzky, and P. L. Stein. 2005. Regulation of NKT cell development by SAP, the protein defective in XLP. Nat. Med. 11: 340-345.
17. Chung, B., A. Aoukaty, J. Dutz, C. Terhorst, and R. Tan. 2005. Signaling lymphocytic activation molecule-associated protein controls NKT cell functions. J. Immunol. 174: 3153-3157. (Pubitemid 40354014)
18. + T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 182: 2091-2096.
19. Wei, D. G., H. Lee, S. H. Park, L. Beaudoin, L. Teyton, A. Lehuen, and A. Bendelac. 2005. Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes. J. Exp. Med. 202: 239-248.
20. + cells. J. Immunol. 164: 2412-2418.
21. Benlagha, K., T. Kyin, A. Beavis, L. Teyton, and A. Bendelac. 2002. A thymic precursor to the NK T cell lineage. Science 296: 553-555.
22. + CD1d-dependent precursor stage. J. Exp. Med. 195: 835-844.
23. Gapin, L., J. L. Matsuda, C. D. Surh, and M. Kronenberg. 2001. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 2: 971-978. (Pubitemid 32976171)
24. Egawa, T., G. Eberl, I. Taniuchi, K. Benlagha, F. Geissmann, L. Hennighausen, A. Bendelac, and D. R. Littman. 2005. Genetic evidence supporting selection of the Vα14i NKT cell lineage from double-positive thymocyte precursors. Immunity 22: 705-716. (Pubitemid 40814501)
25. + stage of thymic ontogeny. Proc. Natl. Acad. Sci. USA 102: 5114-5119.
26. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kundig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261: 609-612. (Pubitemid 23278372)
27. Walunas, T. L., A. I. Sperling, R. Khattri, C. B. Thompson, and J. A. Bluestone. 1996. CD28 expression is not essential for positive and negative selection of thymocytes or peripheral T cell tolerance. J. Immunol. 156: 1006-1013.
28. Vacchio, M. S., J. A. Williams, and R. J. Hodes. 2005. A novel role for CD28 in thymic selection: elimination of CD28/B7 interactions increases positive selection. Eur. J. Immunol. 35: 418-427.
29. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440.
30. Tai, X., M. Cowan, L. Feigenbaum, and A. Singer. 2005. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat. Immunol. 6: 152-162. (Pubitemid 40268196)
31. + regulatory T cells. J. Immunol. 171: 3348-3352.
32. Hathcock, K. S., G. Laszlo, H. B. Dickler, J. Bradshaw, P. Linsley, and R. J. Hodes. 1993. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 262: 905-907. (Pubitemid 24014079)
33. Liu, Y., R. D. Goff, D. Zhou, J. Mattner, B. A. Sullivan, A. Khurana, C. Cantu, III, E. V. Ravkov, C. C. Ibegbu, J. D. Altman, et al. 2006. A modified α-galactosyl ceramide for staining and stimulating natural killer T cells. J. Immunol. Methods 312: 34-39. (Pubitemid 43795980)
34. Borriello, F., M. P. Sethna, S. D. Boyd, A. N. Schweitzer, E. A. Tivol, D. Jacoby, T. B. Strom, E. M. Simpson, G. J. Freeman, and A. H. Sharpe. 1997. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6: 303-313. (Pubitemid 27148597)
35. Fournier, S., J. C. Rathmell, C. C. Goodnow, and J. P. Allison. 1997. T cellmediated elimination of B7.2 transgenic B cells. Immunity 6: 327-339. (Pubitemid 27148599)
36. Harada, Y., M. Tokushima, Y. Matsumoto, S. Ogawa, M. Otsuka, K. Hayashi, B. D. Weiss, C. H. June, and R. Abe. 2001. Critical requirement for the membrane- proximal cytosolic tyrosine residue for CD28-mediated costimulation in vivo. J. Immunol. 166: 3797-3803. (Pubitemid 32224904)
37. Yu, X., R. Abe, and R. J. Hodes. 1998. The role of B7-CD28 co-stimulation in tumor rejection. Int. Immunol. 10: 791-797. (Pubitemid 28279482)
38. Schmidt, E. V., P. K. Pattengale, L. Weir, and P. Leder. 1988. Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma model. Proc. Natl. Acad. Sci. USA 85: 6047-6051.
39. Singer, A., K. S. Hathcock, and R. J. Hodes. 1979. Cellular and genetic control of antibody responses: V. Helper T-cell recognition of H-2 determinants on accessory cells but not B cells. J. Exp. Med. 149: 1208-1226. (Pubitemid 9181924)
40. Benlagha, K., D. G. Wei, J. Veiga, L. Teyton, and A. Bendelac. 2005. Characterization of the early stages of thymic NKT cell development. J. Exp. Med. 202: 485-492. (Pubitemid 41186947)
41. Gadue, P., and P. L. Stein. 2002. NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation. J. Immunol. 169: 2397-2406. (Pubitemid 34920982)
42. Eberl, G., R. Lees, S. T. Smiley, M. Taniguchi, M. J. Grusby, and H. R. MacDonald. 1999. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J. Immunol. 162: 6410-6419. (Pubitemid 29309361)
43. Matsuda, J. L., and L. Gapin. 2005. Developmental program of mouse Vα14i NKT cells. Curr. Opin. Immunol. 17: 122-130.
44. McNab, F. W., D. G. Pellicci, K. Field, G. Besra, M. J. Smyth, D. I. Godfrey, and S. P. Berzins. 2007. Peripheral NK1.1 NKT cells are mature and functionally distinct from their thymic counterparts. J. Immunol. 179: 6630-6637.
45. Chun, T., M. J. Page, L. Gapin, J. L. Matsuda, H. Xu, H. Nguyen, H. S. Kang, A. K. Stanic, S. Joyce, W. A. Koltun, et al. 2003. CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells. J. Exp. Med. 197: 907-918. (Pubitemid 36437867)
46. Schumann, J., P. Pittoni, E. Tonti, H. R. Macdonald, P. Dellabona, and G. Casorati. 2005. Targeted expression of human CD1d in transgenic mice reveals independent roles for thymocytes and thymic APCs in positive and negative selection of Vα14i NKT cells. J. Immunol. 175: 7303-7310. (Pubitemid 41713426)
47. McNab, F. W., S. P. Berzins, D. G. Pellicci, K. Kyparissoudis, K. Field, M. J. Smyth, and D. I. Godfrey. 2005. The influence of CD1d in postselection NKT cell maturation and homeostasis. J. Immunol. 175: 3762-3768.
48. Horai, R., K. L. Mueller, R. A. Handon, J. L. Cannons, S. M. Anderson, M. R. Kirby, and P. L. Schwartzberg. 2007. Requirements for selection of conventional and innate T lymphocyte lineages. Immunity 27: 775-785. (Pubitemid 350102265)
49. L. Immunity 3: 87-98.
50. Okkenhaug, K., L. Wu, K. M. Garza, J. La Rose, W. Khoo, B. Odermatt, T. W. Mak, P. S. Ohashi, and R. Rottapel. 2001. A point mutation in CD28 distinguishes proliferative signals from survival signals. Nat. Immunol. 2: 325-332. (Pubitemid 33706343)
51. L. J. Immunol. 166: 5331-5335.
52. Noel, P. J., M. L. Alegre, S. L. Reiner, and C. B. Thompson. 1998. Impaired negative selection in CD28-deficient mice. Cell Immunol. 187: 131-138. (Pubitemid 28397331)
53. + thymocytes by T cell receptor-induced apoptosis requires a costimulatory signal that can be provided by CD28. J. Exp. Med. 179: 709-713.
54. Chung, Y., R. Nurieva, E. Esashi, Y. H. Wang, D. Zhou, L. Gapin, and C. Dong. 2008. A critical role of costimulation during intrathymic development of invariant NK T cells. J. Immunol. 180: 2276-2283.